Literature DB >> 15593462

Cribriform-morular variant of papillary thyroid carcinoma: clue to early detection of familial adenomatous polyposis-associated colon cancer.

Chisato Tomoda1, Akira Miyauchi, Takashi Uruno, Yuuki Takamura, Yasuhiro Ito, Akihiro Miya, Kaoru Kobayashi, Fumio Matsuzuka, Seiji Kuma, Kanji Kuma, Kennichi Kakudo.   

Abstract

The cribriform-morular variant (CMV) of papillary thyroid carcinoma (PTC) is a rare histologic subtype of PTC that shows a combination of growth patterns including cribriform and spindle cell areas. The thyroid cancer with this unique histology was originally reported in patients with familial adenomatous polyposis (FAP), although it was later found in patients without polyposis as well. Because of its rarity, its clinical features are not clear. We reviewed seven patients with CMV-PTC who were found among 4194 patients with PTC in our pathology files between June 1991 and March 2003. The prevalence of CMV was 0.16% among all PTCs. We invited these patients to our hospital so we could obtain a detailed family history and recommend colonoscopic examination and germline APC gene analysis. Two patients without subjective symptoms had polyposis of the colon and colon cancers. Germline APC gene mutations were found in both patients. The father of a patient who refused the invitation was revealed to have undergone surgery for colon polyposis. In the remaining four patients, neither polyposis nor APC gene mutation was found. Common clinical features included a young age (mean 25 years), predominance of females, circumscribed tumors, negative node metastasis, and no recurrence of the thyroid cancer after surgery. Two of the three patients with colon polyposis had bilateral multiple thyroid tumors, whereas the remaining four (without polyposis) had a solitary tumor. The histopathology of CMV in patients with PTC should arouse a suspicion of FAP, especially if there are multiple tumors. This finding can lead to early detection of colon cancer.

Entities:  

Mesh:

Year:  2004        PMID: 15593462     DOI: 10.1007/s00268-004-7475-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  19 in total

Review 1.  Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus.

Authors:  M Peifer; P Polakis
Journal:  Science       Date:  2000-03-03       Impact factor: 47.728

Review 2.  Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma?

Authors:  J Cameselle-Teijeiro; J K Chan
Journal:  Mod Pathol       Date:  1999-04       Impact factor: 7.842

3.  Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene.

Authors:  Bing Xu; Katsuhiko Yoshimoto; Akira Miyauchi; Seiji Kuma; Noriko Mizusawa; Mitsuyoshi Hirokawa; Toshiaki Sano
Journal:  J Pathol       Date:  2003-01       Impact factor: 7.996

4.  Thyroid cancer in patients with familial adenomatous polyposis.

Authors:  N D Perrier; J A van Heerden; J R Goellner; E D Williams; H Gharib; P Marchesa; J M Church; V W Fazio; D R Larson
Journal:  World J Surg       Date:  1998-07       Impact factor: 3.352

5.  Association of thyroid carcinoma with Gardner's syndrome in siblings.

Authors:  M R Camiel; J E Mulé; L L Alexander; D L Benninghoff
Journal:  N Engl J Med       Date:  1968-05-09       Impact factor: 91.245

6.  Adenomatous polyposis: an association with carcinoma of the thyroid.

Authors:  R O Plail; H J Bussey; G Glazer; J P Thomson
Journal:  Br J Surg       Date:  1987-05       Impact factor: 6.939

7.  Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.

Authors:  P J Morin; A B Sparks; V Korinek; N Barker; H Clevers; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

Review 8.  Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm.

Authors:  H R Harach; G T Williams; E D Williams
Journal:  Histopathology       Date:  1994-12       Impact factor: 5.087

9.  The incidence rate of familial adenomatous polyposis. Results from the Danish Polyposis Register.

Authors:  S Bülow; T Faurschou Nielsen; C Bülow; M L Bisgaard; L Karlsen; F Moesgaard
Journal:  Int J Colorectal Dis       Date:  1996       Impact factor: 2.571

10.  Nuclear localization of immunoreactive beta-catenin is specific to familial adenomatous polyposis in papillary thyroid carcinoma.

Authors:  K Kurihara; S Shimizu; J Chong; T Hishima; N Funata; H Kashiwagi; H Nagai; M Miyaki; M Fukayama
Journal:  Jpn J Cancer Res       Date:  2000-11
View more
  20 in total

1.  Characteristic sonographic features of cribriform papillary thyroid carcinoma for differentiation from other thyroid nodules.

Authors:  Tomoko Fujimoto; Mitsuyoshi Hirokawa; Hisashi Ota; Tomonori Yabuta; Mitsuhiro Fukushima; Kaoru Kobayashi; Nobuyuki Amino; Akira Miyauchi
Journal:  J Med Ultrason (2001)       Date:  2014-07-03       Impact factor: 1.314

2.  Risk of thyroid cancer among Caribbean Hispanic patients with familial adenomatous polyposis.

Authors:  Nicolás Casellas-Cabrera; Yaritza Díaz-Algorri; Víctor J Carlo-Chévere; María González-Pons; Natalia Rodríguez-Mañón; Julyann Pérez-Mayoral; Carlos Bertrán-Rodríguez; Marievelisse Soto-Salgado; Francis M Giardiello; Segundo Rodríguez-Quilichini; Marcia Cruz-Correa
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

3.  Germ-line and somatic mutations of the APC gene and/or ss catenin gene in the occurrence of FAP associated thyroid carcinoma.

Authors:  F Cetta; A Dhamo; G Malagnino; L Barellini
Journal:  World J Surg       Date:  2007-06       Impact factor: 3.352

Review 4.  Cribriform morular variant of papillary thyroid carcinoma in a patient with an incidental neck lump: a case report and review of the literature.

Authors:  Ester Chai Kheng Yeoh; Ling Choo Lim; Siok Bian Ng; Kok Yang Tan; C Rajasoorya
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

5.  Cytoplasmic Lipid Accumulation Characteristic of the Cribriform Variant of Papillary Thyroid Carcinoma.

Authors:  Nami Takada; Mitsuyoshi Hirokawa; Aki Ito; Ayana Suzuki; Miyoko Higuchi; Seiji Kuma; Toshitetsu Hayashi; Tsutomu Daa; Akira Miyauchi
Journal:  Pathobiology       Date:  2017-08-16       Impact factor: 4.342

6.  [Familial thyroid carcinomas].

Authors:  K W Schmid; S Ting; S-Y Sheu
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

Review 7.  [Hereditary thyroid cancer].

Authors:  H Dralle; A Machens; K Lorenz
Journal:  Chirurg       Date:  2008-11       Impact factor: 0.955

8.  Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP.

Authors:  Rachel A Levy; Vanessa W Hui; Rupa Sood; Stephanie Fish; Arnold J Markowitz; Richard J Wong; José G Guillem
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

Review 9.  Pathology of the hereditary colorectal carcinoma.

Authors:  Zoran Gatalica; Emina Torlakovic
Journal:  Fam Cancer       Date:  2007-06-13       Impact factor: 2.375

10.  TERT Promoter Mutation in an Aggressive Cribriform Morular Variant of Papillary Thyroid Carcinoma.

Authors:  Eun Ji Oh; Sohee Lee; Ja Seong Bae; Yourha Kim; Sora Jeon; Chan Kwon Jung
Journal:  Endocr Pathol       Date:  2017-03       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.